Literature DB >> 21688047

Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.

Uk Koo1, Kung-Woo Nam, Ahrom Ham, Dahyun Lyu, Bora Kim, Sung-Jin Lee, Kyeong Ho Kim, Ki-Bong Oh, Woongchon Mar, Jongheon Shin.   

Abstract

Dopamine (DA), as a neurotoxin, can elicit severe Parkinson's disease-like syndrome by elevating intracellular reactive oxygen species (ROS) levels and apoptotic activity. We examined the inhibitory effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide (AETO), purified from the leaves of Laurus nobilis L., on DA-induced apoptosis and α-synuclein (α-syn) formation in dopaminergic SH-SY5Y cells. AETO decreased the active form of caspase-3 and the levels of p53, which were accompanied by increased levels of Bcl-2 in a dose-dependent manner. Flow cytometric and Western blot analysis showed that AETO significantly inhibited DA-induced apoptosis along with suppression of intracellular tyrosinase activity, ROS generation, quinoprotein, and α-syn formation (P < 0.01). These results indicate that AETO inhibited DA-induced apoptosis, which is closely related to the suppression of intracellular tyrosinase activity and the formation of α-syn, ROS, and quinoprotein in SH-SY5Y cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688047     DOI: 10.1007/s11064-011-0523-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  50 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 2.  Pathophysiology of Parkinson's disease.

Authors:  A M Bonnet; J L Houeto
Journal:  Biomed Pharmacother       Date:  1999-04       Impact factor: 6.529

3.  The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease.

Authors:  Isabella Tessari; Marco Bisaglia; Francesco Valle; Bruno Samorì; Elisabetta Bergantino; Stefano Mammi; Luigi Bubacco
Journal:  J Biol Chem       Date:  2008-04-04       Impact factor: 5.157

4.  Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease.

Authors:  Elisa Greggio; Elisabetta Bergantino; Donald Carter; Rili Ahmad; Gertrude-Emilia Costin; Vincent J Hearing; Jordi Clarimon; Andrew Singleton; Johanna Eerola; Olli Hellström; Pentti J Tienari; David W Miller; Alexandra Beilina; Luigi Bubacco; Mark R Cookson
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

5.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 6.  Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.

Authors:  J D Elsworth; R H Roth
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

Review 7.  Oxidative mechanisms in nigral cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

8.  Resveratrol: an original mechanism on tyrosinase inhibition.

Authors:  P Bernard; J Y Berthon
Journal:  Int J Cosmet Sci       Date:  2000-06       Impact factor: 2.970

9.  Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.

Authors:  Yasutaka Ikeda; Shinji Tsuji; Akira Satoh; Masaharu Ishikura; Takuji Shirasawa; Takahiko Shimizu
Journal:  J Neurochem       Date:  2008-11-07       Impact factor: 5.372

10.  Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.

Authors:  Takafumi Hasegawa; Angela Treis; Nadja Patenge; Fabienne C Fiesel; Wolfdieter Springer; Philipp J Kahle
Journal:  J Neurochem       Date:  2008-02-04       Impact factor: 5.372

View more
  2 in total

1.  Laurus nobilis L. Extracts against Paenibacillus larvae: Antimicrobial activity, antioxidant capacity, hygienic behavior and colony strength.

Authors:  Natalia Jorgelina Fernández; Natalia Damiani; Enrique Arturo Podaza; Josefa Fabiana Martucci; Diana Fasce; Federico Quiroz; Pablo Ezequiel Meretta; Silvina Quintana; Martín Javier Eguaras; Liesel Brenda Gende
Journal:  Saudi J Biol Sci       Date:  2018-04-09       Impact factor: 4.219

Review 2.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.